PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22302044-5	2012	Nevertheless, pretreatment of cells with 10058-F4, a specific inhibitor of c-Myc, almost eliminated the nicotinamide-induced radiosensitive effect.	Niacinamide	104-116	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	75-80	
22302044-7	2012	In contrast, nicotinamide attenuated c-Myc protein degradation induced by radiation under hypoxia through inhibition of SirT1 deacetylase activity.	Niacinamide	13-25	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	37-42	
22028816-10	2011	CONCLUSIONS/SIGNIFICANCE: This study demonstrates that nicotinamide plays an important role as a chemo-preventive and therapeutic agent in bladder cancer through the regulation of the Myc oncogenic signature.	Niacinamide	55-67	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	184-187	
1660277-3	1991	The amplified catalase and c-myc genes in HP100-1 cells were not decreased by treatment of the cells with inhibitors of poly(ADP-Ribose) polymerase, such as nicotinamide and benzamide.	Niacinamide	157-169	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	27-32	
18323656-3	2008	Nicotinamide and nicotinamide N-oxide drastically decreased c-myc expression, but isonicotinic acid had no effect, suggesting that these compounds differentiate HL-60 to granulocytes through different pathways.	Niacinamide	0-12	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	60-65	
14716882-1	2003	To explore the preparation method of liposome-mediated 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA and lay foundations for antisense imaging and treatment, antisense oligonucleotides (DNA) with 15 bases and di-functional chelate, hydrazino nicotinamide derivatives, were synthesized.	Niacinamide	260-272	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	108-113	
8136711-4	1993	Whereas c-myc mRNA was suppressed by nicotinamide in proportion to its ability to reduce HASMC growth, down regulation of c-myc by 3-aminobenzamide was much less than the observed antiproliferative effect.	Niacinamide	37-49	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	8-13